Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04024631 · ClinicalTrials.gov registry record · NA
Phenotyping Genetic Risk for Type 2 Diabetes
A NA study of Diabetes Mellitus, Type 2 and Genetics, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT04024631 is a NA study of Diabetes Mellitus, Type 2 and Genetics that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 100 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04024631, a NA study of Diabetes Mellitus, Type 2 and Genetics, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study tests the hypothesis that non-diabetic individuals with a high genetic risk score for type 2 diabetes have impaired glucose tolerance and insulin resistance compared to those with a low genetic risk score for type 2 diabetes.
Conditions Studied
Interventions
- OTHER 75g glucose beverage (Glucola, Trutol, or similar brand)
- OTHER DXA, whole body
Study Locations (2)
Pennsylvania
- Childrens Hospital of Philadelphia - Philadelphia
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-06-17 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04024631
The ClinicalTrials.gov registry entry for NCT04024631 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (98% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which 75g glucose beverage (Glucola, Trutol, or similar brand) is the first listed.
NCT04024631 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04024631 about?
NCT04024631 is a clinical study titled "Phenotyping Genetic Risk for Type 2 Diabetes". This study tests the hypothesis that non-diabetic individuals with a high genetic risk score for type 2 diabetes have impaired glucose tolerance and insulin resistance compared to those with a low genetic risk score for type 2 diabetes.
What is the current status of trial NCT04024631?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2019-06-17. Estimated completion is 2026-06-30.
What conditions does trial NCT04024631 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Genetics.
What interventions are being tested in trial NCT04024631?
The interventions under investigation include: 75g glucose beverage (Glucola, Trutol, or similar brand) (OTHER), DXA, whole body (OTHER).
Who is sponsoring clinical trial NCT04024631?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04024631 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
-
Efficacy of Using Mobile Health Applications for Health
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.